PRO­TACs to RIP­TACs: Arv­inas founder snags $76M for next bet, Hal­da Ther­a­peu­tics

A leader in the pro­tein degra­da­tion space, Yale’s Craig Crews, is back with an­oth­er biotech, Hal­da Ther­a­peu­tics.

On Tues­day, the start­up an­nounced $76 mil­lion in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER